$WHWK

$3.14 -$0.07 (2.18%) Close

$WHWK Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 57.0M shares outstanding

Who owns WHWK?

By type of holder

Institutions 75.9% Insiders 17.8% Everyone else 6.3%

Concentration Top 10 holders own 93.9%

Behzad Aghazadeh 32.1% · Yu Fan 8.5%

Institutional ownership

75.9%

+15.8 pts vs last qtr

Institutional holders

+15 vs last qtr

Net shares bought

+9.0M

by institutions in Q2 2026

New / sold out

28 / 13

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Yu Fan +2.8M
BlackRock, Inc. +1.6M

Biggest sellers in Q2 2026

Balyasny Asset Management L.P. −262.3K
Orbimed Advisors LLC −231.7K

Who is planning to sell?

Notices of proposed sale, last 12 months

$2.6M

4 notices from 3 people

Shares covered

732.5K

1.28% of the company

Arranged in advance

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Lennon David James Officer $1.05M
Giacobello Scott M. Officer $900K

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2022–FY2025

+174.9%

+40.09% a year

Each share's claim on the business

−63.6%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $42.3M

over 4 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years31% 1–3 years51% Under 1 year17%

Quarterly turnover

16.8%

of institutional shares changed hands

Top 10 managers, median time held

1.5 years

Super Investors

Investment managers reporting WHWK on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
YF Yu Fan	4.9M	8.53%	+2.8M (+134.8%)	2025	20.6%
Shares held by quarter Peak holding4.9M (Q2'26) Change over 8 quarters+4.9M Share of the company8.530% Yu Fan's full portfolio →
AC Acuta Capital Partners, LLC 13D · 8.7%	4.7M	8.22%	+1.3M (+37.4%)	2021	15.0%
Shares held by quarter Peak holding4.7M (Q2'26) Change over 8 quarters+2.8M Share of the company8.220% Disclosed stake13D · 8.7% Acuta Capital Partners, LLC's full portfolio →

Yu Fan

4.9M

% of company

8.53%

Change vs last qtr

+2.8M (+134.8%)

Held since

2025

Acuta Capital Partners, LLC

13D · 8.7%

4.7M

% of company

8.22%

Change vs last qtr

+1.3M (+37.4%)

Held since

2021

28 more super investors behind a free account

See every manager holding Whitehawk Therapeutics Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting WHWK on Form N-PORT; together they hold 6.6% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$4.07M	888.0K	1.56%	0.00%	June 30, 2026
IR iShares Russell 2000 ETF iShares Trust	$3.36M	734.1K	1.29%	0.00%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$4.07M

% of company

1.56%

% of the fund

0.00%

As of

June 30, 2026

iShares Russell 2000 ETF

iShares Trust

Position value

$3.36M

% of company

1.29%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Whitehawk Therapeutics Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
BA Behzad Aghazadeh 5%+ holder 13D · 20.0%	18.3M	32.09%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company32.090% Disclosed stake13D · 20.0% View the 13D/G filing →
DA Dalal Anupam Insider	4.7M	8.23%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company8.230% Dalal Anupam's insider activity →

Behzad Aghazadeh

5%+ holder13D · 20.0%

18.3M

% of company

32.09%

Change vs last qtr

—

Held since

—

Dalal Anupam

Insider

4.7M

% of company

8.23%

Change vs last qtr

—

Held since

—

10 more holders behind a free account

See every insider and 5%+ holder of Whitehawk Therapeutics Inc.

Comments